1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 PCR 1.2.3 FISH 1.2.4 DNA Sequencing 1.2.5 Gene Chip 1.3 Market by Application 1.3.1 Global Lung Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clinical Diagnosis 1.3.3 Drug Screening 1.3.4 Research 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Lung Cancer Molecular Diagnostics Market Perspective (2016-2027) 2.2 Lung Cancer Molecular Diagnostics Growth Trends by Regions 2.2.1 Lung Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Lung Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 Lung Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 Lung Cancer Molecular Diagnostics Industry Dynamic 2.3.1 Lung Cancer Molecular Diagnostics Market Trends 2.3.2 Lung Cancer Molecular Diagnostics Market Drivers 2.3.3 Lung Cancer Molecular Diagnostics Market Challenges 2.3.4 Lung Cancer Molecular Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Lung Cancer Molecular Diagnostics Players by Revenue 3.1.1 Global Top Lung Cancer Molecular Diagnostics Players by Revenue (2016-2021) 3.1.2 Global Lung Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021) 3.2 Global Lung Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Lung Cancer Molecular Diagnostics Revenue 3.4 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio 3.4.1 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Molecular Diagnostics Revenue in 2020 3.5 Lung Cancer Molecular Diagnostics Key Players Head office and Area Served 3.6 Key Players Lung Cancer Molecular Diagnostics Product Solution and Service 3.7 Date of Enter into Lung Cancer Molecular Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Lung Cancer Molecular Diagnostics Breakdown Data by Type 4.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021) 4.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) 5 Lung Cancer Molecular Diagnostics Breakdown Data by Application 5.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021) 5.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Lung Cancer Molecular Diagnostics Market Size (2016-2027) 6.2 North America Lung Cancer Molecular Diagnostics Market Size by Type 6.2.1 North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) 6.2.2 North America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) 6.2.3 North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027) 6.3 North America Lung Cancer Molecular Diagnostics Market Size by Application 6.3.1 North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) 6.3.2 North America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) 6.3.3 North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027) 6.4 North America Lung Cancer Molecular Diagnostics Market Size by Country 6.4.1 North America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) 6.4.2 North America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Lung Cancer Molecular Diagnostics Market Size (2016-2027) 7.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type 7.2.1 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) 7.2.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) 7.2.3 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027) 7.3 Europe Lung Cancer Molecular Diagnostics Market Size by Application 7.3.1 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) 7.3.2 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) 7.3.3 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027) 7.4 Europe Lung Cancer Molecular Diagnostics Market Size by Country 7.4.1 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) 7.4.2 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size (2016-2027) 8.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type 8.2.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027) 8.3 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application 8.3.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027) 8.4 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region 8.4.1 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Lung Cancer Molecular Diagnostics Market Size (2016-2027) 9.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Type 9.2.1 Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) 9.2.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) 9.2.3 Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027) 9.3 Latin America Lung Cancer Molecular Diagnostics Market Size by Application 9.3.1 Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) 9.3.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) 9.3.3 Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027) 9.4 Latin America Lung Cancer Molecular Diagnostics Market Size by Country 9.4.1 Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) 9.4.2 Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size (2016-2027) 10.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type 10.2.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2027) 10.3 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application 10.3.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2027) 10.4 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country 10.4.1 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Foundationmedicine 11.1.1 Foundationmedicine Company Details 11.1.2 Foundationmedicine Business Overview 11.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Introduction 11.1.4 Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.1.5 Foundationmedicine Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Lung Cancer Molecular Diagnostics Introduction 11.2.4 Roche Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Qiagen 11.3.1 Qiagen Company Details 11.3.2 Qiagen Business Overview 11.3.3 Qiagen Lung Cancer Molecular Diagnostics Introduction 11.3.4 Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.3.5 Qiagen Recent Development 11.4 Liferiver 11.4.1 Liferiver Company Details 11.4.2 Liferiver Business Overview 11.4.3 Liferiver Lung Cancer Molecular Diagnostics Introduction 11.4.4 Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.4.5 Liferiver Recent Development 11.5 Tellgen 11.5.1 Tellgen Company Details 11.5.2 Tellgen Business Overview 11.5.3 Tellgen Lung Cancer Molecular Diagnostics Introduction 11.5.4 Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.5.5 Tellgen Recent Development 11.6 Genetech 11.6.1 Genetech Company Details 11.6.2 Genetech Business Overview 11.6.3 Genetech Lung Cancer Molecular Diagnostics Introduction 11.6.4 Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.6.5 Genetech Recent Development 11.7 Gpmedical 11.7.1 Gpmedical Company Details 11.7.2 Gpmedical Business Overview 11.7.3 Gpmedical Lung Cancer Molecular Diagnostics Introduction 11.7.4 Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.7.5 Gpmedical Recent Development 11.8 Sansure 11.8.1 Sansure Company Details 11.8.2 Sansure Business Overview 11.8.3 Sansure Lung Cancer Molecular Diagnostics Introduction 11.8.4 Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.8.5 Sansure Recent Development 11.9 Amoydx 11.9.1 Amoydx Company Details 11.9.2 Amoydx Business Overview 11.9.3 Amoydx Lung Cancer Molecular Diagnostics Introduction 11.9.4 Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.9.5 Amoydx Recent Development 11.10 Mole 11.10.1 Mole Company Details 11.10.2 Mole Business Overview 11.10.3 Mole Lung Cancer Molecular Diagnostics Introduction 11.10.4 Mole Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.10.5 Mole Recent Development 11.11 Annoroad 11.11.1 Annoroad Company Details 11.11.2 Annoroad Business Overview 11.11.3 Annoroad Lung Cancer Molecular Diagnostics Introduction 11.11.4 Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) 11.11.5 Annoroad Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of PCR Table 3. Key Players of FISH Table 4. Key Players of DNA Sequencing Table 5. Key Players of Gene Chip Table 6. Global Lung Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Lung Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Lung Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Lung Cancer Molecular Diagnostics Market Share by Regions (2016-2021) Table 10. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Lung Cancer Molecular Diagnostics Market Share by Regions (2022-2027) Table 12. Lung Cancer Molecular Diagnostics Market Trends Table 13. Lung Cancer Molecular Diagnostics Market Drivers Table 14. Lung Cancer Molecular Diagnostics Market Challenges Table 15. Lung Cancer Molecular Diagnostics Market Restraints Table 16. Global Lung Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Lung Cancer Molecular Diagnostics Market Share by Players (2016-2021) Table 18. Global Top Lung Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2020) Table 19. Ranking of Global Top Lung Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Lung Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Lung Cancer Molecular Diagnostics Product Solution and Service Table 23. Date of Enter into Lung Cancer Molecular Diagnostics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021) Table 27. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Lung Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021) Table 31. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 63. Foundationmedicine Company Details Table 64. Foundationmedicine Business Overview Table 65. Foundationmedicine Lung Cancer Molecular Diagnostics Product Table 66. Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 67. Foundationmedicine Recent Development Table 68. Roche Company Details Table 69. Roche Business Overview Table 70. Roche Lung Cancer Molecular Diagnostics Product Table 71. Roche Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 72. Roche Recent Development Table 73. Qiagen Company Details Table 74. Qiagen Business Overview Table 75. Qiagen Lung Cancer Molecular Diagnostics Product Table 76. Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 77. Qiagen Recent Development Table 78. Liferiver Company Details Table 79. Liferiver Business Overview Table 80. Liferiver Lung Cancer Molecular Diagnostics Product Table 81. Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 82. Liferiver Recent Development Table 83. Tellgen Company Details Table 84. Tellgen Business Overview Table 85. Tellgen Lung Cancer Molecular Diagnostics Product Table 86. Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 87. Tellgen Recent Development Table 88. Genetech Company Details Table 89. Genetech Business Overview Table 90. Genetech Lung Cancer Molecular Diagnostics Product Table 91. Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 92. Genetech Recent Development Table 93. Gpmedical Company Details Table 94. Gpmedical Business Overview Table 95. Gpmedical Lung Cancer Molecular Diagnostics Product Table 96. Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 97. Gpmedical Recent Development Table 98. Sansure Company Details Table 99. Sansure Business Overview Table 100. Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 101. Sansure Recent Development Table 102. Amoydx Company Details Table 103. Amoydx Business Overview Table 104. Amoydx Lung Cancer Molecular Diagnostics Product Table 105. Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 106. Amoydx Recent Development Table 107. Mole Company Details Table 108. Mole Business Overview Table 109. Mole Lung Cancer Molecular Diagnostics Product Table 110. Mole Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 111. Mole Recent Development Table 112. Annoroad Company Details Table 113. Annoroad Business Overview Table 114. Annoroad Lung Cancer Molecular Diagnostics Product Table 115. Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million) Table 116. Annoroad Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Lung Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. PCR Features Figure 3. FISH Features Figure 4. DNA Sequencing Features Figure 5. Gene Chip Features Figure 6. Global Lung Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027 Figure 7. Clinical Diagnosis Case Studies Figure 8. Drug Screening Case Studies Figure 9. Research Case Studies Figure 10. Lung Cancer Molecular Diagnostics Report Years Considered Figure 11. Global Lung Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Lung Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Lung Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027 Figure 14. Global Lung Cancer Molecular Diagnostics Market Share by Regions (2022-2027) Figure 15. Global Lung Cancer Molecular Diagnostics Market Share by Players in 2020 Figure 16. Global Top Lung Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Molecular Diagnostics Revenue in 2020 Figure 18. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021) Figure 19. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) Figure 20. North America Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027) Figure 22. North America Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027) Figure 23. North America Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027) Figure 24. United States Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027) Figure 28. Europe Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027) Figure 29. Europe Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027) Figure 30. Germany Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Lung Cancer Molecular Diagnostics Market Share by Region (2016-2027) Figure 40. China Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027) Figure 48. Latin America Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027) Figure 49. Latin America Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027) Figure 50. Mexico Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Lung Cancer Molecular Diagnostics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Lung Cancer Molecular Diagnostics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Lung Cancer Molecular Diagnostics Market Share by Country (2016-2027) Figure 56. Turkey Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Lung Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Foundationmedicine Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 60. Roche Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 61. Qiagen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 62. Liferiver Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 63. Tellgen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 64. Genetech Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 65. Gpmedical Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 66. Sansure Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 67. Amoydx Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 68. Mole Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 69. Annoroad Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Foundationmedicine Roche Qiagen Liferiver Tellgen Genetech Gpmedical Sansure Amoydx Mole Annoroad